[Treatment of rheumatoid arthritis with cytokine antagonists].
The blockade of proinflammatory cytokines is an interesting experimental approach for the therapy of rheumatoid arthritis. Various biological inhibitors are currently being tested in a number of large clinical studies with encouraging results. This review summarizes the existing data and discusses potential future developments.
Manger
B
B
Medizinische Klinik III mit Poliklinik, Friedrich-Alexander-Universität Erlangen-Nürnberg.
D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology*; D004338:Drug Combinations; D006801:Humans; D007375:Interleukin-1 / Q000037:antagonists & inhibitors*; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D004338:Drug Combinations; D007375:Interleukin-1; D011993:Recombinant Fusion Proteins; D014409:Tumor Necrosis Factor-alpha